Cocker Paul John, Rotge Jean-Yves, Daniel Marie-Laure, Belin-Rauscent Aude, Belin David
Department of Psychology, University of Cambridge, Cambridge, UK.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Psychiatrie d'Adultes, Paris, France.
Addict Biol. 2020 May;25(3):e12738. doi: 10.1111/adb.12738. Epub 2019 Mar 7.
Impairments in cost-benefit decision making represent a cardinal feature of drug addiction. However, whether these alterations predate drug exposure, thereby contributing to facilitating loss of control over drug intake, or alternatively arise as a result of drug use and subsequently confer vulnerability to relapse has yet to be determined. Male Sprague-Dawley rats were trained to self-administer (SA) cocaine during 19 daily long-access (12-h) sessions; conditions reliably shown to promote escalation. One week after cocaine SA, rats underwent an extinction/relapse test immediately followed by conditioned stimuli-, stress-, and drug-primed reinstatement challenges. The influence of escalated cocaine intake on decision making was measured over time by four test sessions of a rodent analogue of the Iowa Gambling Task (rGT), once prior to cocaine exposure and then 1 day, 1 week, and 1 month after the last SA session. Substantial individual variability was observed in the influence of escalated cocaine SA on decision-making performance. A subset of rats displayed pronounced deficits, while others showed unaffected or even improved performance on the rat Gambling Task (rGT) 24 hours after the last SA session. When challenged with a relapse test after 1 week of forced abstinence, animals that showed impaired decision making following SA displayed an increased propensity to respond for cocaine under extinction. These data suggest that decision-making deficits in individuals with drug addiction are not antecedent to-but arise as a consequence of-drug exposure. Moreover, these data indicate that susceptibility to the deleterious effects of drugs on decision making confers vulnerability toward relapse.
成本效益决策受损是药物成瘾的一个主要特征。然而,这些改变是在药物接触之前就已出现,从而促使对药物摄入失去控制,还是相反,是由于药物使用而产生,随后导致复吸的易感性,还有待确定。雄性Sprague-Dawley大鼠在19个每日长时间给药(12小时)的实验环节中接受可卡因自我给药(SA)训练;这些条件已被可靠地证明会促进药物摄入量增加。在可卡因SA一周后,大鼠立即接受消退/复吸测试,随后进行条件刺激、应激和药物引发的复吸挑战。通过对爱荷华赌博任务(rGT)的啮齿动物类似物进行四个测试环节,在可卡因接触前一次,以及在最后一次SA实验环节后的1天、1周和1个月时,测量随时间推移可卡因摄入量增加对决策的影响。在可卡因SA摄入量增加对决策表现的影响方面观察到了很大的个体差异。一部分大鼠表现出明显的缺陷,而其他大鼠在最后一次SA实验环节24小时后的大鼠赌博任务(rGT)中表现未受影响甚至有所改善。在强制戒断1周后进行复吸测试时,那些在SA后表现出决策受损的动物在消退状态下对可卡因反应的倾向增加。这些数据表明,药物成瘾个体的决策缺陷并非先于药物接触出现,而是药物接触的结果。此外,这些数据表明,药物对决策的有害影响的易感性会导致复吸的易感性。